15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells (Q44195479)

30 November 2017

title

15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells (English)

1 reference

30 November 2017

2

Arta Monjazeb

1 reference

30 November 2017

Carl E Clay

1

1 reference

30 November 2017

Jacqueline Thorburn

series ordinal

3

1 reference

30 November 2017

Floyd H Chilton

series ordinal

4

1 reference

30 November 2017

Kevin P High

series ordinal

5

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Journal of Lipid Research

30 November 2017

published in

1 reference

30 November 2017

volume

43

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

1818-1828

1 reference

Roles of PPARs in health and disease.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Lessons from the glitazones: a story of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

The nature and composition of 15-deoxy-Delta(12,14)PGJ(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Ubiquitin proteasome pathway: implications and advances in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Proteasome inhibition in cancer: development of PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Relationship between arachidonate--phospholipid remodeling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Intracellular unesterified arachidonic acid signals apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Peroxisome proliferator-activated receptors in inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200224-JLR200

10.1194/JLR.M200224-JLR200

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference